JPY 1952.0
(1.56%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 2.48 Billion | 2.21 Billion | 2.38 Billion | 1.94 Billion | 2.3 Billion | 272.88 Million |
Net Income | 2.06 Billion | 2.47 Billion | 2.01 Billion | 1.09 Billion | 1.87 Billion | 1.32 Billion |
Depreciation & Amortization | 293 Million | 306 Million | 311.1 Million | 198.56 Million | 93 Million | 151.98 Million |
Deferred income taxes | -724 Million | - | -311.68 Million | -408.15 Million | -522.5 Million | - |
Stock-based compensation | 17 Million | 21 Million | 7 Million | 90.67 Million | 80.2 Million | - |
Change in working capital | -127 Million | -259 Million | 463.12 Million | 894.96 Million | 767.79 Million | -1.02 Billion |
Other non-cash items | 966 Million | -326 Million | -91.01 Million | 66.79 Million | 4.27 Million | -180.01 Million |
Investing Cash Flow | 212 Million | -1.25 Billion | -631.03 Million | -753.34 Million | 723.41 Million | 332 Million |
Investments in PPE | -45 Million | -126 Million | -219.04 Million | -471.03 Million | -219.06 Million | -77.11 Million |
Acquisitions | - | 1 Million | -56.43 Million | -245.55 Million | 5.73 Million | -175 Thousand |
Investment purchases | - | -1.24 Billion | -790.5 Million | -368.2 Million | -2.63 Billion | -1.82 Billion |
Sales/Maturities of investments | 290 Million | 115 Million | 402.92 Million | 368.23 Million | 3.32 Billion | 2.24 Billion |
Other Investing Activities | -33 Million | -3 Million | 32.01 Million | -36.78 Million | 242.37 Million | -10.26 Million |
Financing Cash Flow | -858 Million | 882 Million | -374.74 Million | -215.07 Million | 1.21 Billion | -1.78 Billion |
Debt repayment | -38 Million | -2.05 Billion | -1.68 Billion | -3.09 Billion | -2.41 Billion | -1.58 Billion |
Dividends payments | -896 Million | -726 Million | -664.33 Million | -641.07 Million | -490.38 Million | -375.14 Million |
Common Stock Repurchased | - | - | -167.95 Million | - | -79 Thousand | -72 Thousand |
Common Stock Issuance | - | 44 Million | 27.1 Million | 19.66 Million | 906.56 Million | 170.08 Million |
Other Financing Activities | 200 Million | 3.61 Billion | 2.11 Billion | 3.5 Billion | 3.21 Billion | -1000.00 |
Accounts receivables | -232 Million | -114 Million | -43.3 Million | 17.8 Million | -63.08 Million | -209.58 Million |
Accounts payables | 16 Million | 102 Million | 49.93 Million | 21.7 Million | 31.88 Million | 2.57 Million |
Inventory | 95 Million | -1.65 Billion | 196.38 Million | 1.03 Billion | 331.32 Million | -1.27 Billion |
Other working capital | -6 Million | 1.4 Billion | 260.1 Million | -174.63 Million | 467.66 Million | 254.76 Million |
Cash at beginning of period | 12.8 Billion | 10.86 Billion | 9.42 Billion | 8.49 Billion | 4.19 Billion | 5.38 Billion |
Cash at end of period | 14.69 Billion | 12.8 Billion | 10.86 Billion | 9.42 Billion | 8.49 Billion | 4.19 Billion |
Capital Expenditure | -45 Million | -126 Million | -219.04 Million | -471.03 Million | -219.06 Million | -77.11 Million |
Effect of forex changes on cash | 49 Million | 92 Million | 54.05 Million | -44.08 Million | -270 Thousand | -6.82 Million |
Net cash flow / Change in cash | 1.89 Billion | 1.93 Billion | 1.43 Billion | 929.92 Million | 4.29 Billion | -1.18 Billion |
Free Cash Flow | 2.44 Billion | 2.09 Billion | 2.17 Billion | 1.47 Billion | 2.08 Billion | 195.76 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 604 Million | 608 Million | 2.06 Billion | 795 Million | 435 Million | 541 Million |
Depreciation & Amortization | - | - | 293 Million | 74 Million | 74 Million | 73 Million |
Deferred income taxes | - | - | -724 Million | - | - | - |
Stock-based compensation | - | - | 17 Million | - | - | - |
Change in working capital | - | - | -127 Million | - | - | - |
Other non-cash items | -604 Million | -608 Million | 966 Million | -795 Million | -435 Million | -541 Million |
Investing Cash Flow | - | - | 212 Million | - | - | - |
Investments in PPE | - | - | -45 Million | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | 290 Million | - | - | - |
Other Investing Activities | - | - | -33 Million | - | - | - |
Financing Cash Flow | - | - | -858 Million | - | - | - |
Debt repayment | - | - | -38 Million | - | - | - |
Dividends payments | - | - | -896 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | 200 Million | - | - | - |
Accounts receivables | - | - | -232 Million | - | - | - |
Accounts payables | - | - | 16 Million | - | - | - |
Inventory | - | - | 95 Million | - | - | - |
Other working capital | - | - | -6 Million | - | - | - |
Cash at beginning of period | - | - | 12.8 Billion | 11.82 Billion | 11.64 Billion | 11.38 Billion |
Cash at end of period | - | - | 14.69 Billion | 14.69 Billion | 11.82 Billion | 11.64 Billion |
Capital Expenditure | - | - | -45 Million | - | - | - |
Effect of forex changes on cash | - | - | 49 Million | - | - | - |
Net cash flow / Change in cash | - | - | 1.89 Billion | 2.86 Billion | 179 Million | 268 Million |
Free Cash Flow | - | - | 2.44 Billion | 148 Million | 148 Million | 146 Million |
GZTGF
9530
1618
4015
NGLFINE
THEMISMED